A carregar...

Endostatin: A novel inhibitor of androgen receptor function in prostate cancer

Acquired resistance to androgen receptor (AR)-targeted therapies compels the development of novel treatment strategies for castration-resistant prostate cancer (CRPC). Here, we report a profound effect of endostatin on prostate cancer cells by efficient intracellular trafficking, direct interaction...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Lee, Joo Hyoung, Isayeva, Tatyana, Larson, Matthew R., Sawant, Anandi, Cha, Ha-Ram, Chanda, Diptiman, Chesnokov, Igor N., Ponnazhagan, Selvarangan
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4321255/
https://ncbi.nlm.nih.gov/pubmed/25605930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1417660112
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!